Servier Bio-innovation Llc

This study is testing three new experimental immunotherapy drugs, each combined with an existing immunotherapy called cemiplimab, for adults with advanced non-small cell lung cancer who haven't had prior treatment. The goal is to see if these combinations are safe and can help co…

This study is testing the safety and effectiveness of a new drug, S095029, when given alongside an existing immunotherapy (pembrolizumab) for people with advanced stomach or esophageal cancer that has a specific genetic pattern (MSI-H/dMMR). The trial has two parts: first to find…